These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2275893)

  • 1. Efficacy of sotalol in controlling reentrant supraventricular tachycardias.
    Millar RN
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():625-9. PubMed ID: 2275893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous sotalol in patients with atrioventricular accessory pathways.
    Touboul P; Atallah G; Kirkorian G; Lavaud P; Mathieu MP; Dellinger A
    Am Heart J; 1987 Sep; 114(3):545-50. PubMed ID: 3630895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M; Breithardt G
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of almokalant, a selective potassium channel blocker, on the termination and inducibility of paroxysmal supraventricular tachycardias: a study in patients with Wolff-Parkinson-White syndrome and atrioventricular nodal reentrant tachycardia. Almokalant PSVT Study Group.
    Darpö B; Edvardsson N
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):198-206. PubMed ID: 7475043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M; Kuhl AJ; Lüderitz B
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome.
    Liu S; Yuan S; Hertervig E; Kongstad O; Olsson SB
    J Electrocardiol; 2001 Oct; 34(4):295-301. PubMed ID: 11590556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electropharmacology of sotalol in patients with Wolff-Parkinson-White syndrome.
    Mitchell LB; Wyse DG; Duff HJ
    Circulation; 1987 Oct; 76(4):810-8. PubMed ID: 2820614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Wolff-Parkinson-White syndrome presenting spontaneous mutual frequent transition between atrioventricular reciprocating tachycardia and atrioventricular nodal re-entrant tachycardia.
    Kondo H; Shinohara T; Otsubo T; Miyoshi M; Fukui A; Tsuchiya T; Takahashi N
    J Electrocardiol; 2018; 51(3):467-469. PubMed ID: 29478804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sotalol in patients with Wolff-Parkinson-White syndrome.
    Kunze KP; Schlüter M; Kuck KH
    Circulation; 1987 May; 75(5):1050-7. PubMed ID: 3568305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test.
    Calkins H; Sousa J; el-Atassi R; Rosenheck S; de Buitleir M; Kou WH; Kadish AH; Langberg JJ; Morady F
    N Engl J Med; 1991 Jun; 324(23):1612-8. PubMed ID: 2030717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation.
    Daubert C; Mabo P; Gras D; Leclercq C
    Eur Heart J; 1993 Nov; 14 Suppl H():67-73. PubMed ID: 7904939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of atrioventricular tachycardia].
    Seipel L; Kühlkamp V
    Ther Umsch; 1992 Aug; 49(8):536-42. PubMed ID: 1519182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant Wolff-Parkinson-White and Atrioventricular Nodal Reentrant Tachycardia: Which Pathway to Ablate?
    Sarsam S; Sidiqi I; Shah D; Zughaib M
    Am J Case Rep; 2015 Dec; 16():872-5. PubMed ID: 26655223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
    Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS
    Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute therapy of tachycardic arrhythmias. 2: Supraventricular tachycardia--atrioventricular tachycardia (WPW syndrome)].
    Gonska BD; Rab J
    Fortschr Med; 1995 Mar; 113(7):87-9. PubMed ID: 7750890
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual induction of slow-fast atrioventricular nodal reentrant tachycardia. Report of two cases.
    Calò L; Riccardi R; Scaglione M; Caponi D; Golia P; Gaita F
    G Ital Cardiol; 1999 Nov; 29(11):1318-22. PubMed ID: 10609133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Ludmer PL; McGowan NE; Antman EM; Friedman PL
    J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.